Carthera receives FDA Breakthrough Device Designation for SonoCloud-9 System

Breakthrough Status allows for enhanced interaction with FDA and recognizes SonoCloud system as innovative and promising approach for treatment of recurrent glioblastoma Paris, France, June 22, 2022 – Carthera, a French company that designs and develops SonoCloud, an innovative ultrasound-based medical device to tre...

Related Keywords

United States ,Paris ,France General ,France ,French ,Michael Canney ,Alexandre Carpentier ,Sandra Thiolli ,Breakthrough Device Program ,European Innovation Council ,National Institutes Of Health ,Drug Administration ,Breakthrough Devices Program ,Radiological Health ,Sorbonne University ,National Research Agency ,Breakthrough Status ,Breakthrough Device ,Blood Brain Barrier ,Breakthrough Designation ,Breakthrough Devices Designation ,Device Designation ,Premarket Approval ,Breakthrough Device Designation ,National Institutes ,